Monte Rosa Therapeutics, Inc. (GLUE)

NASDAQ: GLUE · IEX Real-Time Price · USD
11.61
+1.02 (9.63%)
Jul 6, 2022 4:00 PM EDT - Market closed

Balance Sheet (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 202120202019
Cash & Equivalents
351.4142.869.25
Cash & Cash Equivalents
351.4142.869.25
Cash Growth
719.84%363.63%-
Other Current Assets
-0.730.51
Total Current Assets
348.6743.599.76
Property, Plant & Equipment
12.334.621.34
Other Long-Term Assets
5.341.160
Total Long-Term Assets
17.665.791.34
Total Assets
366.3349.3811.09
Accounts Payable
6.567.073.2
Current Debt
000.75
Other Current Liabilities
10.0822.210.35
Total Current Liabilities
16.6429.284.29
Other Long-Term Liabilities
2.181.07-
Total Long-Term Liabilities
2.181.070
Total Liabilities
18.8130.344.29
Total Debt
000.75
Common Stock
471.570.410.05
Retained Earnings
-122.04-48.08-12.2
Comprehensive Income
-2.02-1.060
Shareholders' Equity
347.52-48.73-12.15
Total Liabilities and Equity
366.33-18.39-7.86
Net Cash / Debt
351.4142.868.5
Net Cash / Debt Growth
719.84%404.57%-
Net Cash Per Share
14.0628.261.70
Working Capital
332.0314.325.47
Book Value Per Share
13.90-32.12-2.43
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).